|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1446 Duke Street |
Address2 |
|
City | Alexandria |
State | VA |
Zip Code | 22314 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 28481-12
|
||||||||
|
6. House ID# 316440000
|
TYPE OF REPORT | 8. Year | 2022 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Jennifer Popik |
Date | 4/19/2022 3:28:03 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Contacts in support of retaining all current pro-life appropriations riders in FY22 appropriations.
Contacts in support of retaining pro-life riders in ongoing Covid-19-related appropriations.
Contacts in opposition to the "Build Back Better" reconciliation bill in current form due to funding of abortion in various healthcare programs.
Contacts regarding NDAA (the National Defense Authorization Act) related to the funding of abortion.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
|
Casey |
Coffin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CON
16. Specific lobbying issues
Contacts in opposition to legislative or executive actions that seek to add to the U.S. Constitution the language of the "Equal Rights Amendment" that originally was submitted to the states by the 92nd Congress as H.J. Res. 208 on March 22,1972, which failed ratification effective March 22, 1979. This includes:
-- opposition to H.J. Res. 17 and S.J. Res. 1, resolutions purporting by multiple unconstitutional mechanisms to retroactively nullify the seven-year ratification deadline that was included in the Proposing Clause of H.J.Res. 208 of the 92nd Congress.
-- opposition to any actions by any component of the Executive Branch that would seek to evade or ignore the insurmountable constitutional obstacles and court decisions barring resuscitation of the 1972 Equal Rights Amendment, including but not limited to opposition to schemes to pressure the Archivist of the United States to certify the ERA in contravention of federal court rulings and the legal positions of the Department of Justice.
-- opposition to H.Res. 891 (Speier), declaring "the sense of the House of Representatives" that the Equal Rights Amendment is part of the Constitution.
-- opposition to H.J. Res. 28 (Maloney), "Proposing an amendment to the Constitution of the United States relative to equal rights for men and women."
Contacts in opposition to the nomination of Ketanji Brown Jackson to the Supreme Court.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Jennifer |
Popik |
|
|
|
Casey |
Coffin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FAM
16. Specific lobbying issues
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age as well as similar legislation (not introduced).
Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion.
Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition.
Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation.
Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions.
Contacts regarding legislation to ensure affiliate rules in law are applied to abortion providers receiving Paycheck Protection Program (PPP) loans in violation of the law.
Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter.
Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken.
Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620). No position taken.
Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343/H.R. 6702 and others not introduced).
Contacts in support of the Heartbeat Bill (H.R. 705 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable.
Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind.
Contacts in opposition to agency action expanding the use of tissue from aborted babies.
Contacts in regards to FDA oversight of prenatal testing products and efficacy.
Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions.
Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293).
Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486.
Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome.
Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs.
Contacts in opposition to regulation to make abortion drugs available by telemedicine.
Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present.
Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877) based on lack of clarity and erroneous legal premises.
Contacts in support of the Women's Right to Know Act (not introduced) to give women truthful, non-misleading information prior to an abortion.
Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a State line, with the intent that the minor obtain an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision
Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes.
Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions.
Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions.
Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion.
Contacts in support of Protecting Life on College Campus, which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty.
Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18). Contacts in support of defeating a Previous Question in order to initiate a procedure to provide for the immediate consideration of HR 18, the No Taxpayer Funding for Abortion Act, sponsored by Rep. Chris Smith (R-NJ). The Smith bill would make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions.
Contacts in opposition to the Women's Health Protection Act (H.R. 3577) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development.
Contacts regarding the Care for Her Act (H.R. 5163) to extend services for pregnant women.
Contacts regarding the Family Violence Prevention Act (H.R. 2119) in regards to abortion expanding provisions.
Contacts in opposition to changes to Title X regulations which bar grantees from co-locating with abortion clinics or referring clients for abortions including support of a CRA overturning Biden administration regulation (S.J.Res. 41/H.J.Res. 76).
Contacts in support of the Simon Crosier Act (H.R. 5656) which requires certain policies to be in place relating to do-not-resuscitate orders or similar physicians orders for unemancipated minors receiving services.
Contacts in support of the Pregnancy Loss Mental Health Research Act of 2021 (H.R. 5995) to provide research on, and services for, individuals with clinical mental health complications following a pregnancy loss.
Contacts in support of Stopping Traffickers and Their Accomplices Act of 2022 (H.R.6536) which would require abortionists to report reasonable suspicion of sex trafficking.
Contacts in regards to Data Mapping to Save Moms Lives Act (H.R.1218) and impact on abortion reporting. No position taken this quarter.
Contacts in support of the Protecting Girls with Turner Syndrome Act of 2022 (H.R.7179) which would prohibit the performance of an abortion on an unborn child due to a diagnosis of Turner syndrome.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
|
Casey |
Coffin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Contacts regarding strengthening guidance to providers that it is discriminatory to fail to offer suicide prevention services in states where assisted suicide is legal.
Contacts regarding strengthening guidance to providers against steering patients away from treatment.
Contacts regarding prescription drug reform, so as not to prevent people from accessing current life-saving medication, and prevent new innovative medications from coming to market.
Contacts regarding COBRA coverage and inclusion of Hyde Amendment protections.
Contacts in support of enforcing the fund-segregation requirements of the 2010 "Affordable Care Act" with respect to abortion and to adopt penalties for noncompliance, including support for a CRA (S.J.Res. 43/H.J.Res. 79)regarding Biden administration regulation.
Contacts in regards to the Cures 2.0 legislation (H.R. 6000) with respect to abortion.
Contacts in opposition to Robert Califf to the FDA due to issues related to loosening of restrictions on chemical abortion drugs.
Contacts in support of legislation (not introduces) to prohibit abortions from being counted as an eligible medical expense for Health Savings Accounts.
Contacts regarding the VIPER Act (H.R. 5721) in regards to concerns over use of fetal tissue in research.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
|
Casey |
Coffin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
|
Casey |
Coffin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Insurance-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
|
Casey |
Coffin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOR
16. Specific lobbying issues
Contacts in support of limitations on funding of abortion-promoting groups in any FY 2022 Foreign Operations appropriations vehicle.
Contacts in support of the Protecting Life in Foreign Assistance Act (S.137/H.R.534) to would ensure that no funds may be made available to foreign non-governmental organizations, multi-lateral nonprofits, and quasi-autonomous non-governmental organizations that perform abortions, counsel for abortion, lobby for abortion policies or expanded access, or provide funding or resources for any entity, including domestic non-governmental organizations and non-profits, that perform abortions abroad.
Contacts in opposition to the Global HER Act (H.R. 556/S.142) because it would permanently eliminate the "Mexico City Policy."
Contacts in opposition to U.N. efforts regarding assertions that international human rights law should guide the Supreme Court, and claims that laws protecting unborn children are violations of the United States obligations under the human rights treaties it has signed and ratified.
Contacts in regards to H.R. 5497, the BURMA Act, related to inclusion of the Helms Amendment. No position taken.
Contacts in regards to H.R. 6968/H.Res. 972 with respect to the Global Magnitsky act and retaining the current definition of what constitutes a gross violations of internationally recognized human rights.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
|
Casey |
Coffin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
Contacts regarding the enforcement of the Smith Amendment as it related to the enforcement of the prohibition on paying for abortion in members of Congress and staff healthcare plans.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
|
Casey |
Coffin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CIV
16. Specific lobbying issues
Contacts in opposition to the Equality Act (H.R. 5/S. 393) because this legislation contains language that could be construed to create a right to demand abortion from health care providers, and likely would place at risk the authority of state and federal government to prohibit taxpayer-funded abortions.
Contacts in opposition to the For the People Act of 2021 and Freedom to Vote Act (H.R. 1/S.1/S. 2093/S.2747/H.R. 5746/H.R. 2747 H.9/S.9) because this legislation would severely impede the exercise of our organizations constitutional rights, and the rights and privacy of our donors and supporters.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
|
Casey |
Coffin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Contacts in support of the Child Tax Credit for Pregnant Moms Act of 2022 (S.3537/H.R. 6505) which would allow a child tax credit for an unborn child who is born alive, miscarried, or was stillborn.
Contacts in support of the No Abortion Bonds Act (H.R. 606) to prohibit the use of tax-exempt municipal bonds to finance the construction of elective abortion providers.
Contacts in support of the Abortion is Not Health Care Act (S.124/H.R.380) to end the preferential tax treatment of abortion.
Contacts in support of the Protecting Life in Health Savings Accounts Act (S. 125) to end the preferential tax treatment of abortion in health savings accounts.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
|
Casey |
Coffin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRA
16. Specific lobbying issues
Contacts in regards to Care is an Economic Development Strategy Act or the CEDS Act (H.R. 5547) and potential abortion funding issues. No position taken.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SCI
16. Specific lobbying issues
Contacts in regards to the America Competes Act of 2022 (H.R. 4521) and whether healthcare tax credits could fund abortion services. No position taken this quarter.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |